Brief: Quanterix Terminates Executives Of Akoya Biosciences
18/07/2025 23:26
July 18 (Reuters) - Quanterix Corp QTRX.O: QUANTERIX CORP - ON JULY 14, TERMINATES EXECUTIVES OF AKOYA BIOSCIENCES - SEC FILING QUANTERIX CORP - TERMINATIONS EXPECTED TO SAVE $2.8 MILLION ANNUALLY - SEC FILING QUANTERIX CORP - EXPENSES OF $3.3 MILLION EXPECTED FOR SEVERANCE IN 2025 - SEC FILING Further company coverage: QTRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Quanterix
See all newsBrief: Alzpath And Quanterix Expand Strategic Licensing Agreement To Advance Next Generation Alzheimer's Disease Biomarker Research
Quanterix Corporation reports results for the quarter ended June 30 - Earnings Summary
Quanterix Q2 revenue rises 34% but cuts 2026 outlook
Quanterix Corporation expected to post a loss of 46 cents a share - Earnings Preview
Quanterix Corp expected to post a loss of 46 cents a share - Earnings Preview